FDA Rejects AstraZeneca&#39;s Exanta
15055
AstraZeneca Plc (AZN) on Friday said US regulators did not approve its anti-clotting drug Exanta. The US Food and Drug Administration followed the advice of an advisory panel, which last
364629
Edwards Lifesciences Corp. (EW.N: Quote, Profile, Research) on Friday said it does not expect the US Food and Drug Administration to provide an answer on whether it can conduct a clinical
704224
U.S. regulators won't approve Allergan  Inc.'s AGN.N experimental treatment for the skin disorder  psoriasis based on the data submitted, the company said on  Monday.
564304
WASHINGTON/LONDON  - An FDA review AstraZeneca  Plc's  under the name Coumadin.
726866
US regulators said certain promotional materials for Johnson &amp; Johnson&#39;s epilepsy drug Topamax fail to disclose serious risks linked to the medicine and asked the company to immediately cease using them.
515226
A federal judge denied a request by Pfizer (nyse: PFE - news - people ) to halt competitors&#39; sales of gabapentin, a generic form of Pfizer&#39;s Neurontin epilepsy drug.
371559
Drugs giant AstraZeneca today acknowledged that its anti-clotting drug Exanta is unlikely to win US approval any time soon and revealed a one-year delay with another new drug, Galida, for diabetes.
735577
Shares in OSI Pharmaceuticals (OSIP :Nasdaq - news - research) and Genentech (DNA :Nasdaq - news - research) jumped Friday after AstraZeneca (AZN :NYSE - news - research) said new medical data showed its lung cancer drug Iressa provided no survival
356288
By Rosie Murray-West, City Correspondent (Filed: 14/09/2004). Astrazeneca shares plummeted yesterday as investors and analysts digested the pharmaceutical giant&#39;s announcement over potential blockbuster drug Exanta.
433316
AstraZeneca Plc, the UK&#39;s second-biggest drugmaker, delayed the regulatory filing of its diabetes medicine Galida by a year to 2007, a setback that comes a month after US scientists questioned
78720
China rejected a warning issued by the U.S. Food and Drug Administration urging consumers to avoid using Chinese toothpaste because it may contain a poisonous chemical used in antifreeze.
582959
U.S. regulators have rejected  GlaxoSmithKline Plc's  experimental drug gepirone ER for  adults with major depression.
408832
Swiss drugmaker Roche Holding AG is taking legal action against Israel's Teva Pharmaceutical Industries Ltd  in the United States to prevent Teva from selling a generic version of Roche osteoporosis drug Boniva, Roche said on Tuesday.
140812
WASHINGTON (CBS.MW) - An advisory panel to the Food and Drug Administration late Friday declined to endorse AstraZeneca&#39;s anti-stroke drug, Exanta.
481177
Hostile environment prompts root and branch review. Exanta unlikely to win US approval in near future. By Stephen Foley. AstraZeneca, the UK&#39;s number two pharmaceuticals company, has launched a &quot;root and branch
728653
The UK&#39;s second largest pharmaceutical company, AstraZeneca, yesterday admitted another setback in the development of some of its drugs, as it delayed the expected launch of diabetes treatment Galida for a year.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.